Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Triggering through CD40 promotes interleukin-4-induced CD23 production and enhanced soluble CD23 release in atopic disease

  • Robin L.K. Paterson
  • , Gideon Lack
  • , Jeanne M. Domenico
  • , Guy Delespesse
  • , Donald Y.M. Leung
  • , Terri H. Finkel
  • , Erwin W. Gelfand
  • Natl. Jewish Ctr. Immunol. Resp. M.
  • University of Montreal
  • Unknown
  • National Jewish Medical and Research Center

Producción científicarevisión exhaustiva

14 Citas (Scopus)

Resumen

The pathogenesis of atopic disease is closely linked to the overproduction of IgE. CD23 and CD40 are two cellular receptors involved in the regulation of IgE production and both receptors are elevated in atopic disease. We have examined the role of CD40 in the regulation of CD23 and soluble CD23 production in healthy and atopic donors. Triggering of the B cell CD40 receptor directly enhances interleukin (IL)-4-mediated up-regulation of CD23 at both the protein and the mRNA level. When atopic donors were studied, the synergistic effect of CD40 triggering on the IL-4-induced up-regulation of CD23 and soluble CD23 (sCD23) was enhanced and there was a relative skewing toward production of sCD23. These studies implicate the CD40 receptor in the hyperproduction of CD23 and sCD23 in atopic disease and suggest that abnormalities may exist in the cellular pathways leading to sCD23 production.

Idioma originalEnglish
Páginas (desde-hasta)1979-1984
Número de páginas6
PublicaciónEuropean Journal of Immunology
Volumen26
N.º9
DOI
EstadoPublished - 1996
Publicado de forma externa

Huella

Profundice en los temas de investigación de 'Triggering through CD40 promotes interleukin-4-induced CD23 production and enhanced soluble CD23 release in atopic disease'. En conjunto forman una huella única.

Citar esto